Universal Health Services, Inc. (UHS)
ROE
Obliczenia
|
2023/Q4 (31 gru 2023) |
2023/Q3 (30 wrz 2023) |
2023/Q2 (30 cze 2023) |
2023/Q1 (31 mar 2023) |
2022/Q4 (31 gru 2022) |
2022/Q3 (30 wrz 2022) |
2022/Q2 (30 cze 2022) |
2022/Q1 (31 mar 2022) |
||
|---|---|---|---|---|---|---|---|---|---|
| Zysk netto (ttm) | w tys. USD | 717 487 | 675 839 | 691 537 | 684 183 | 674 861 | 738 871 | 774 191 | 934 656 |
| Kapitał własny | w tys. USD | 6 149 000 | 6 064 920 | 6 087 180 | 6 012 110 | 5 920 580 | 5 855 350 | 5 814 660 | 5 867 870 |
| ROE | 11,67% | 11,14% | 11,36% | 11,38% | 11,40% | 12,62% | 13,31% | 15,93% |
2023/Q4 obliczenia
ROE = Zysk netto (ttm) ÷ Kapitał własny
= $717 487K ÷ $6 149 000K
= 11,67%
Analiza porównawcza
2023/Q4
Nazwa spółki
Symbol
ROE
Universal Health Services, Inc.
UHS
11,67%
Acadia Healthcare Company Inc
ACHC
-0,78%
Encompass Health Corp
EHC
21,22%
Ensign Group Inc
ENSG
14,04%
HCA Healthcare Inc
HCA
—
National Healthcare Corp.
NHC
7,35%
Pediatrix Medical Group Inc
MD
-7,11%
Select Medical Holdings Corporation
SEM
18,22%
Tenet Healthcare Corp.
THC
38,00%